Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 74139

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 12, 2016
Product types
Device
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Baxter Healthcare Corp

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 3

COSEAL Surgical Sealant Kit, 2 mL, Product Code: 934070; For use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.

Z-1838-2016
Recall number
Z-1838-2016
Initiated
May 12, 2016
Classification
Class II
Status
Terminated
Recalling firm
Baxter Healthcare Corp
Quantity
274 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use.

Code information

HA160136

Distribution pattern

Distributed US (nationwide) including Puerto Rico and in the Bahamas, Canada, and Singapore.

device · product 2 of 3

COSEAL Surgical Sealant Kit, 4 mL, Product Code: 934071; For use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.

Z-1839-2016
Recall number
Z-1839-2016
Initiated
May 12, 2016
Classification
Class II
Status
Terminated
Recalling firm
Baxter Healthcare Corp
Quantity
6,804 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use.

Code information

HA160151, HA151205, HA151036, HA151035, HA160229

Distribution pattern

Distributed US (nationwide) including Puerto Rico and in the Bahamas, Canada, and Singapore.

device · product 3 of 3

COSEAL Surgical Sealant Kit, 8 mL, Product Code: 934072; For use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.

Z-1840-2016
Recall number
Z-1840-2016
Initiated
May 12, 2016
Classification
Class II
Status
Terminated
Recalling firm
Baxter Healthcare Corp
Quantity
6,128 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use.

Code information

HA151038, HA151220, HA151037, HA151028, HA160114, HA160115, HA160222

Distribution pattern

Distributed US (nationwide) including Puerto Rico and in the Bahamas, Canada, and Singapore.